...
...

gilead sciences news

Borderlands 4: Release date, time, where to play, editions and more

Borderlands 4 release date, time and more
us
Published on Sept 08, 2025 09:20 pm IST

Objections on Gilead’s HIV drug patent claims to be heard

Gilead has several patent applications in India on lenacapavir. Two of these patent applications, filed in 2020, seek patents on the choline and sodium salt of the drug lenacapavir. (HT PHOTO)
india news
Published on Sept 18, 2024 07:47 am IST

Anti-inflammatory drug may shorten Covid-19 recovery time

A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized Covid-19 patients shortens their time to recovery by an additional day.
world news
Updated on Jan 10, 2021 12:21 am IST

Covid-19 vaccine update: Latest on Gilead’s remdesivir, Moderna’s experimental candidate and others

Gilead Sciences Inc’s remdesivir is at the forefront of the efforts to treat the disease after it helped shorten hospital recovery times in a clinical trial.
world news
Updated on Jul 15, 2020 08:46 am IST

Remdesivir shortage hits Delhi as requirement soars

An increase in cases around the country has seen more doctors prescribing the drug , but supply hasn’t increased proportionately. Patients prescribed the drug are typically given six doses (each is an injection).
delhi news
Updated on Jul 09, 2020 01:17 am IST

Covid-19 updates: South Africa begins first trials for Covid-19 vaccine

FILE PHOTO: Phials of an mRNA type vaccine candidate for the coronavirus disease (Covid-19) are pictured at Chulalongkorn University during the development of an mRNA type vaccine in Bangkok, Thailand.
world news
Updated on Jun 25, 2020 10:42 am IST

From Chinese anti-Covid-19 shots, latest on remdesivir to Patanjali’s coronavirus drugs: Top updates

File photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration.
india news
Updated on Jun 24, 2020 11:02 am IST

Covid-19: Trials for inhaled version of remdesivir to start in August

The totality of these data shows that remdesivir has the potential to be of meaningful benefit to patients with Covid-19.
india news
Updated on Jun 24, 2020 05:50 am IST

AstraZeneca eyes potential merger with Gilead Sciences

Shares of AstraZeneca have risen about 41% over the past 12 months, making it the best performer on a Bloomberg Intelligence index of major Western pharmaceutical companies.
business
Published on Jun 08, 2020 04:43 am IST

AstraZeneca approaches Gilead Sciences about potential merger

AstraZeneca, valued at $140 billion, is the UK’s biggest drugmaker by market capitalization and has developed treatments for conditions from cancer to cardiovascular disease.
business
Published on Jun 07, 2020 02:20 pm IST

India’s drug regulator grants Gilead Sciences marketing authorisation for remdesivir

The approval was given following consultation with the subject expert committee of the Central Drugs Standard Control Organisation (CDSCO).
india news
Updated on Jun 02, 2020 07:33 am IST

Gilead says Remdesivir Drug helped moderately ill Covid-19 patients

Remdesivir is the only treatment that’s been shown in a rigorous experiment to help fight the coronavirus.
world news
Updated on Jun 02, 2020 06:53 am IST

India must consider ways to get access to remdesivir: Nirmal K Ganguly

india news
Updated on May 01, 2020 11:41 pm IST
View more
Home / Topic / Gilead Sciences / News
Sign in
Sign out
Subscribe Now
Copyright © HT Digital Streams Ltd. All rights reserved.